Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CCND1 inhibitors(Cyclin D1 inhibitors), MYC inhibitors(Myc proto-oncogene protein inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | US | 18 Jul 2022 |